New review clears silicone gel breast implants of serious health risks; Vanderbilt-Ingram Cancer Center researchers find no cancer link

Women who receive silicone gel-filled breast implants do not have a higher risk of breast cancer or other cancers and do not experience lower survival rates after breast cancer diagnosis, according to a new report published in the November issue of Annals of Plastic Surgery. This is the first exhaustive review in almost a decade of the health effects of cosmetic breast implants.

Prostate cancer patients may be eligible for less invasive therapy; Vanderbilt-Ingram Cancer Center first in state to test new ultrasound procedure

Men with prostate cancer now may have access to a new, minimally invasive surgical procedure. Urologic surgeons at Vanderbilt-Ingram Cancer Center will be the first in Tennessee to test the new Ablatherm procedure, which uses high-intensity focused ultrasound (HIFU) to destroy cancerous prostate tissue without any incision.

Vanderbilt-Ingram clinic space expanding to meet needs of patients

When the dust settles on a new renovation project involving Vanderbilt-Ingram Cancer Center‘s Henry-Joyce Cancer Clinic, waiting room space and exam rooms will nearly double to help meet the needs of an ever increasing number of cancer patients in Middle Tennessee and beyond.

Vanderbilt-Ingram Cancer Center Receives Highest Level of Approval

Vanderbilt-Ingram Cancer Center has received a three-year accreditation with commendation, the highest level of approval, from the Commission on Cancer of the American College of Surgeons (ACoS).

Vanderbilt-Ingram Cancer Center receives $6.5 million grant to study tumor environment

Like a seed needs soil to grow and flourish, a tumor relies on its environment to grow and spread in the body — something the Vanderbilt-Ingram Cancer Center will be exploring more closely with the help of a new $6.5 million grant from the National Cancer Institute (NCI).

Pietenpol Named Interim Director of Vanderbilt-Ingram Cancer Center

Jennifer A. Pietenpol, Ph.D., has been selected to lead the Vanderbilt-Ingram Cancer Center as interim director.

1 4 5 6 7 8 9